Hayakawa N, Kikuchi E, Mizuno R, Oya M. The role of programmed cell death-1 positivity in tumor nest on clinical outcome in upper tract urothelial carcinoma patients treated with radical nephroureterectomy. EMUC 2017, O3.
Omalizumab vermindert jeuk gerelateerd aan checkpointremmers en anti-HER2-therapieën
jun 2021 | Borstkanker, Immuuntherapie, Longoncologie, Uro-oncologie